|
211 |
A pilot double-blind, placebo-controlled, randomized clinical trial of MitoQ in the treatment of septic shock: evaluating its effects on clinical outcomes and oxidative stress biomarker
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 18.8.2025: 1-14
|
|
|
|
212 |
Evaluation of oral nano-curcumin formulation effectiveness in patients with mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind clinical trial
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 18.8.2025: 1-13
|
|
|
|
213 |
Impact of royal jelly consumption on oxidative stress, anti-oxidant markers and physical activities of patients with multiple sclerosis: a randomized double-blind placebo-controlled study
Enthalten in Irish journal of medical science 18.8.2025: 1-12
|
|
|
|
214 |
Response to Letter to the Editor: Effect of BCG vaccination on immune-regulatory markers and glycemic control in children with new-onset type 1 diabetes mellitus (T1DM): a randomised double-blinded placebo-controlled pilot trial
Enthalten in International journal of diabetes in developing countries 18.8.2025: 1-2
|
|
|
|
215 |
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial
Enthalten in Psychopharmacology 16.8.2025: 1-11
|
|
|
|
216 |
A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women
Enthalten in Osteoporosis international 15.8.2025: 1-12
|
|
|
|
217 |
Effects of Probiotics on Markers of Oxidative/Nitrosative Stress and Damage Associated with Inflammation in Non-communicable Diseases: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Enthalten in Probiotics and Antimicrobial Proteins 15.8.2025: 1-22
|
|
|
|
218 |
Evaluation of the effect of fluoxetine on depression and anxiety levels in hemodialysis patients with major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial
Enthalten in International urology and nephrology 14.8.2025: 1-11
|
|
|
|
219 |
Quantifying placebo and trial participation effects on cognitive outcome measures in aging dogs
Enthalten in GeroScience 11.8.2025: 1-18
|
|
|
|
220 |
Promising efficacy of oral nano-silymarin formulation on prevention of vancomycin-induced nephrotoxicity: a randomized, triple-blinded, placebo-controlled clinical trial
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 5.8.2025: 1-13
|
|
Administration
